NCT06239259 Validity and Reliability of Thai Version Clinical Questionnaire for Diagnosis of Carpal Tunnel Syndrome
| NCT ID | NCT06239259 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Siriraj Hospital |
| Condition | Carpal Tunnel Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-07-06 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2023-07-06 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Kamath and Stothard clinical questionnaire for diagnosing carpal tunnel syndrome (CTS) is a valid score for diagnosis of CTS. However it haven't been translated in to Thai version and the validity and accuracy of the Thai the Thai version have not been yet verified. The research team recognizes the importance and potential benefits of adapting this assessment for use within the Thai population.Therefore, we aim to conduct this research to translate the questionnaire from the original English to Thai and to assess its validity and reliability for diagnosing patients with Carpal Tunnel Syndrome.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years and older who are admitted to Siriraj Hospital with signs and symptoms consistent with carpal tunnel disease. * Diagnosis of carpal tunnel disease was confirm with electrodiagnostic study and electromyography * Must be able to communicate in Thai. Exclusion Criteria: * Patients diagnosed with other neurological diseases such as cerebrovascular disease, cervical radiculopathy, diabetic neuropathy, tumors of the nerve endings in the arm, and other peripheral neuropathy. * Pregnancy or breastfeeding * History of recieving chemotheraphy agent * Patient who recieved surgical treatment for carpal tunnel syndrome.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06239259 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06239259 currently recruiting?
Yes, NCT06239259 is actively recruiting participants. Contact the research team at panai.lao@mahidol.ac.th for enrollment information.
Where is the NCT06239259 trial being conducted?
This trial is being conducted at Bangkok Noi, Thailand.
Who is sponsoring the NCT06239259 clinical trial?
NCT06239259 is sponsored by Siriraj Hospital. The trial plans to enroll 80 participants.